Non-invasive Monitoring: Impact on Patient Management and Outcomes
Enhancing patient monitoring in SNFs and ALFs is crucial due to challenges in recognizing deteriorating health. Gaps in vital sign checks lead to missed indicators and adverse outcomes. Turtle Shell Technologies' Dozee Pro NX offers continuous non-invasive monitoring, alerting healthcare providers of vital sign changes. This clinical study aims to evaluate Dozee Pro Nx's impact on patient outcomes, practitioner efficiency, and healthcare costs in SNFs and ALFs, addressing gaps in care delivery.
- EligibilityCriteria: Inclusion Criteria:  Age 18 years or older. Weight between 40kg-120kgs  Exclusion Criteria:  Terminal illness with a life expectancy of less than 1 month. Have any condition that could interfere with the subject's ability to lie flat or stable on the bed Needs the use of equipment whose operation can interfere with Investigation System operations Patients planned to be transferred from the facility within 72 hours Prisoners Pregnant - HealthyVolunteers: No - Gender: All - MinimumAge: 18 Months - MaximumAge: 120 Years - StdAgeList: Child, Adult, Older Adult - StudyPopulation: The study will be conducted on subjects in the age group above 18 years regardless of gender. The study is done on patients admitted in the SNF who fulfill the inclusion and exclusion criteria - SamplingMethod: Non-Probability Sample